INSTRUMENT FOR MEASURING CARBON MONOXIDE POISONING OF HUMANS USING IN VIVO NIRS TECHNOLOGY

• US 20080269577A1
• Filed: 04/25/2007
• Published: 10/30/2008
• Est. Priority Date: 04/25/2007
• Status: Abandoned Application

• Current Assignee: Neurophysics Corporation
• Original Assignee: Neurophysics Corporation
• Inventors: STODDART, Hugh Franklin, STODDART, Hugh Adam, SEFRANEK, Thomas Christopher John, OLDEN, Timothy Hanson, MARTIN, Dale John
• Application Number:
  US11/739,880
• Publication Number:
  US 20080269577A1
• Time in Patent Office: Days
• US Class Current: 600/322
• CPC Class Codes: A61B 5/14551 for measuring blood gases

Abstract

Spectral, frequency based non-invasive procedure for determination of blood constituents utilizing in vivo NIRS (Near-Infrared Spectrum) technology, which is the measurement of the near-infrared absorption spectrum within a region of the living human body for the purpose of identifying tissue and blood components and their concentrations and more particularly to novel applications and methodology for determining the optical response, measurements and calculations relating to the concentrations of individual chromophores in the bloodstream and particularly to the level of CO chromophores in the tissues of an animal or human being.

Claims

1. A method for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject, the method comprising the steps of:

imparting a wavelength range of light comprising visible and near-infrared components to a light delivery fiberoptic;

passing the wavelength range of light through a selected tissue sample of the human or animal subject and receiving an unabsorbed portion of the wavelength range of light in a light collecting fiberoptic;

providing a spectrometer for receiving the unabsorbed portion of the wavelength range of light from the light collecting fiberoptic;

determining a total absorption spectrum of the selected tissue sample for a plurality of wavelengths selected from the wavelength range of light; and

comparing an absorption of the plurality of chromophores at a first wavelength to an absorption of the plurality of chromophores at one or more additional wavelengths to determine a relative amount of each of the plurality of chromophores in the blood of a human or animal subject.

2. The method for non-invasively determining the relative amount of at least one chromophore in the blood of a human or animal subject as set forth in claim 1 further comprising the step of impinging the selected tissue surface portion with broadband infrared light.

3. The method for non-invasively determining the relative amount of at least one chromophore in the blood of a human or animal subject as set forth in claim 1 further comprising the step of impinging the selected tissue surface portion with broadband infrared light in a range equal to and greater than 450 nm.

4. The method for non-invasively determining the relative amount of at least one chromophore in the blood of a human or animal subject as set forth in claim 1 further comprising the step of impinging different wavelengths of light on a nasal septum of the human or animal subject and detecting the spectral distribution of the light emerging from the selected tissue sample;

and determining multiple absorption values of the light in this selected tissue sample.

5. The method of for non-invasively determining the relative amount of at least one chromophore in the blood of a human or animal subject as set forth in claim 1 further comprising the step of determining a first absorption value of the light in the hemoglobin of the arterial blood flow through the selected tissue sample and comparing to at least a second absorption value determined at a different time from the first absorption value, and evaluating the rate of change between the first absorption value and the second absorption value.

6. The method for non-invasively determining the relative amount of at least one chromophore in the blood of a human or animal subject as set forth in claim 1 further comprising the step of determining the relative percentages of oxyhemoglobin, carboxyhemoglobin and deoxyhemoglobin in the blood in accordance with multiple wavelength absorption values.

7. The method as set forth in claim 1 for non-invasively determining the relative amounts of the plurality of chromophores in the blood of a human or animal subject, the method further comprising the steps of determining the light absorption through the selected tissue sample for at least as many wavelengths of light as the plurality of chromophores for which it is desired to obtain a relative amount in the blood of the human or animal subject.

8. The method for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject as set forth in claim 7, the method further comprising the steps of passing the selected wavelengths of light through a nasal septum being the selected tissue sample of the human or animal subject.

9. An apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject comprising:

a light source imparting a wavelength range including visible and broadband infrared light to a light delivery fiberoptic;

a light collecting fiberoptic for receiving the light after the light has passed through a selected tissue sample of the human or animal subject; and

a spectrometer for measuring the intensity of substantially all wavelengths of light received by the light collecting fiberoptic.

10. The apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject as set forth in claim 9 wherein the light source imparts short intense pulses of visible and -infrared light to the transmitting fiberoptic.

11. The apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject as set forth in claim 10 wherein the broadband light imparted by the light source is in the range of at least about 450 nanometers to 650 nanometers. (Why this range?)

12. The apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject as set forth in claim 9 wherein the light delivery fiberoptic and the light collecting fiberoptic have free ends maintained in a substantially parallel relationship to define a tissue sample receiving space between the free ends of the fiberoptics.

13. The apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject as set forth in claim 12 wherein an end surface of the light delivery fiberoptic is formed at about a 45 degree angle relative to the longitudinal axis of the fiberoptic, and an end surface of the light collecting fiberoptic is also formed at about a 45 degree angle, and both end surfaces are provided with a reflective coating thereon so that the light is directed perpendicularly through the tissue sample.

14. The apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject as set forth in claim 9 wherein the selected tissue sample is the nasal septum of the human or animal subject.

15. The apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject as set forth in claim 9 wherein the light source comprises an incandescent lamp which is pulsed by discharging a capacitor through a filament of the lamp.

16. The apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject as set forth in claim 9 wherein the light source comprises a short-arc xenon lamp and shutter.

17. The apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject as set forth in claim 9 wherein the light source imparting the visible and infrared light to the light delivery fiberoptic further comprises a reference fiberoptic connected directly between the light source and the spectrometer.

18. The apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject as set forth in claim 17 wherein the light source imparts a plurality of sequentially different light sources to the spectrometer within a desired time period.

19. The apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject as set forth in claim 18 wherein the light source sequentially imparts the light from the light delivery fiberoptic and the light from the reference fiberoptic to the spectrometer.

20. The apparatus for non-invasively determining the relative amounts of a plurality of chromophores in the blood of a human or animal subject as set forth in claim 19 wherein the ambient light spectra is measured sequentially with the light from the light delivery fiberoptic and the light from the reference fiberoptic to the spectrometer.